FDA Center for Drug Evaluation & Research Issues Warning Letter to Zhejiang Gaorong Cosmetic
October 22, 2026
October 22, 2026
WASHINGTON, Oct. 22 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Zhejiang Gaorong Cosmetic Co. Ltd. from its Center for Drug Evaluation and Research:
* * *
Recipient: Ms. Yunji (Lucy) Gao, Facility Contact, Zhejiang Gaorong Cosmetic Co., Ltd., No. 88 Xixi Street Linjiang Industrial Park, Jinhua Shi Zhejiang Sheng, 321204, China, Lucy@gaorongcosmetic.com
Issuing Office: Cen . . .
* * *
Recipient: Ms. Yunji (Lucy) Gao, Facility Contact, Zhejiang Gaorong Cosmetic Co., Ltd., No. 88 Xixi Street Linjiang Industrial Park, Jinhua Shi Zhejiang Sheng, 321204, China, Lucy@gaorongcosmetic.com
Issuing Office: Cen . . .